Product Information

METHYLPREDNISOLONE 4 MG DOSEPK is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1454 per EA under NDC 59762444002. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPREDNISOLONE 4 MG DOSEPK

methylprednisolone
$0.1454per EA

Strength

4 mg/1

NDC

59762444002

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METHYLPREDNISOLONE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA011153

FDA Approved

Before 1982

TE Code

AB

On Market Since

10/11/2011

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for METHYLPREDNISOLONE 4 MG DOSEPK has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 82.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1454 per EA
All-time high$0.8134 (Dec 11, 2013)
All-time low$0.0962 (Nov 20, 2024)
52-week high$0.1454
52-week low$0.1124
Median price$0.2257
Average price$0.3164
Largest weekly change-31.4% (Nov 20, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+0.9%

1M

+6.9%

3M

+15.6%

6M

+28.3%

1Y

+17.4%

3Y

+1.7%

5Y

-21.6%

All

-82.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPREDNISOLONE 4 MG DOSEPK?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 4 MG DOSEPK, manufactured by Mylan Pharmaceuticals Inc., is $0.1454 per EA (NDC 59762444002), effective Nov 18, 2026.

How has the price of METHYLPREDNISOLONE 4 MG DOSEPK changed over time?

Over the history we have for it, the NADAC for METHYLPREDNISOLONE 4 MG DOSEPK has declined 82.1%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 4 MG DOSEPK?

Since Nov 28, 2013, the NADAC for METHYLPREDNISOLONE 4 MG DOSEPK has ranged from a low of $0.0962 (Nov 20, 2024) to a high of $0.8134 (Dec 11, 2013), with a median of $0.2257 per EA.

Are there cheaper alternatives to METHYLPREDNISOLONE 4 MG DOSEPK?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPREDNISOLONE 4 MG TABLET, is $0.1127 per EA — about 23% below METHYLPREDNISOLONE 4 MG DOSEPK.

Who manufactures METHYLPREDNISOLONE 4 MG DOSEPK?

METHYLPREDNISOLONE 4 MG DOSEPK (NDC 59762444002) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.